LONDON (Alliance News) - Alliance Pharma PLC Chairman David Cook said Thursday the company is trading in line with management views.
The company generated good cash flow and continued to reduce its ratio of adjusted net debt to earnings before interest, tax, depreciation and amortisation.
In his annual general meeting statement Cook added: "We continue to see good growth from our International Star brand Kelo-cote, for scar reduction, and the continued international rollout of MacuShield. Our two most recent acquisitions in December 2017, Vamousse and Ametop, are performing in line with expectations."
Shares in the pharma company were trading up 0.7% at 89.80 pence.
Alliance Pharma (APH)